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Abstract
Steven Johnson Syndrome and Toxic Epidermal
Necrolysis are rare but severe form of hypersensitivity
inflammatory reactions to multiple offending agents
including drugs. Acetaminophen is extensively used due to
its analgesic and anti-pyretic properties. It is rendered to be
relatively safe, with hepatotoxicity considered to be the
major adverse effect. However, very few cases of Steven
Johnson Syndrome and Toxic Epidermal Necrolysis have
been reported with acetaminophen usage in the past. We
present the case of a 40 years old lady who developed an
overlap of the two condition after taking several doses of
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acetaminophen for fever. She presented with widespread
maculopapular rash, stinging in the eyes, oral mucosal
ulcerations and high grade fever. She was successfully
treated with corticosteroid therapy along with the
supportive treatment. This case addresses the fact, that
severe hypersensitivity reactions can occur with
acetaminophen which can be potentially life threatening.
Keywords: Steven Johnson Syndrome, Toxic Epidermal
Necrolysis, Acetaminophen, Corticosteroids.

Introduction
Steven-Johnson Syndrome (SJS) is an infrequent but
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a severe form of adverse hypersensitivity reaction to drugs
which results in skin and mucosal eruptions that can be
potentially lethal. It is considered to be a less severe form of
Toxic Epidermal Necrolysis (TEN), the difference being the
extent of epidermal detachment; <10% and>30% of the
total body surface area, respectively while 10%-30% is
known as SJS-TEN overlap.1 The incidence of SJS has been
estimated to be around 1-6 per 1,000,000 persons per year
with a mortality rate of 1-5% which rises up to 30% in
TEN.2 Multiple drugs have been identified to cause SJS and
TEN, antibiotics (sulfonamides) being the most common.
Acetaminophen is amongst the most extensively
used analgesic and anti-pyreticbecause of easy availability
and cost-effectiveness. Despite being considered relatively
safe, adverse reactions including cutaneous hypersensitivity
reactions have been reported.3 However, very few cases of
SJS and TEN have been reported as being associated
exclusively with acetaminophen usage.4-6
We present the case of a previously healthy lady who
developed SJS-TEN overlap after acetaminophen ingestion.

Case Report
A 40-year oldlady, with no co-morbids developed

Figure-2: Shows dusky red cutaneous lesions on the back with some of them
coalescing to form plaques.

high grade fever of 39°C (102.2°F) one evening. She took
TWO tablets of Acetaminophen after which the fever
subsided but recurred next morning. The dose of
Acetaminophen was repeated and the condition started
worsening with oedema of lips, oral mucosal ulcerations
and stinging in eyes. Rashes appeared later that evening.
She consulted a physician who continued her on
Acetaminophen and added Cetrizine which she did not take.
She reported to our emergency department next
morning. She was diagnosed as having a self-limiting
hypersensitivity reaction and administered a dose of
intravenous Ketorolac (30mg) for pain and fever and was
discharged. She returned in 24 hours with spread of rashes,
bilateral conjunctivitis, oedema and crusting of lips (Figure1), pruritus, oral ulcerations, salivation, myalgia and fever
of 39°C. Acetaminophen was stopped immediately and IV
Clemastine (1mg) and IV Hydrocortisone (100 mg) together
with Ringer Lactate solution were administered. She was
later shifted to the ward.

Figure-1: Shows oedema and crusting of the lips with erythematous purpuric macular
lesions involving the neck.
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According to the patient, the rashes started as dusky
red macular lesions in the palms and later extended
symmetrically involving her arms, forearms, eyes, trunk,
neck, soles and legs in the order of sequence. Some of the
lesions became papular. On examination, she was vitally
stable. Erythematous maculopapularlesions were observed
covering around 25% of total body surface area. The rashes
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had coalesced to form plaques in the arms, back and head
and neck region (Figure-2). The genitals were spared and no
blister formation was seen. Other systemic examination was
unremarkable. Based on the case history and examination,
she was diagnosed clinically with SJS-TEN overlap by a
consultant dermatologist.
The patient reported to have had complaints of
diarrhoea and vomiting after acetaminophen usage in the
past. Similar complaints were also associated with intake of
wheat products, potatoes, beef and several vegetables. Her
child had fever and flu like symptoms since one week.
Other personal and family history was unremarkable.
Baseline investigations revealed a Haemoglobin
level of 11.3g/dl, leukocytes 4.7x109/L with neutrophils of
82%, lymphocytes 11.0% and eosinophils 0.2% followed by
a normal count the next day. Platelets were reduced to
129x109/L (150-400) initially. Sodium was observed to be
140 (135-145) mmol/l, Potassium 3.3 (3.6-5.0) MEQ/L,
Chloride 108 (101-111) and Bicarbonate 18.8 (21-31)
mmol/L. Renal and liver function tests were normal. Blood
and urine culture were sent which were negative after 5
days. Mycoplasma pneumonia serology and Malarial ICT
were negative. Urine analysis and chest x-ray were normal.
The following medications were administered:
Hydrocortisone (100mg) every 8 hours and Clemastine
(1mg) every 12 hours intravenously for 5 days along with
supportive treatment. Topical application of Gentamicin
drops (1ml) for conjunctivitis, Clobetasol ointment
(5grams) for cutaneous lesions and Fluticasone Propionate
cream (0.05%) for lesions on the face were prescribed.
Nystatin oral drops and a mouthwash were started for oral
hygiene. Pregabalin(75mg) per-oral twice a day was also
added to counter the burning sensation particularly on
palms and soles.
During her hospital stay, she complained of
dysphagia which indicated the esophageal involvement of
SJS-TEN overlap. Her mouth opening was limited and she
was kept on soft diet due to ulcerations. She also
complained of dryness and irritation in eyes. Laboratory
evaluation revealed hypokalaemia (3.3 mmol/l) and
reduced bicarbonate levels (19 mmol/l) that normalized
after potassium and fluid resuscitation (28 mmol/l). She
responded to the treatment and was significantly better
after 5 days. She remained afebrile and generalized
subsidence in rashes was observed with improved
salivation and swelling of lips.She was discharged on oral
Prednisolone, Cetrizine, Pregabalin and topical
medications. The dose of steroids was gradually tapered
over two weeks. On two weeks follow up, there was
considerable resolution of rashes and oedema of the lips.
Sloughing off of skin was noted in palms and soles with
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new skin formation. Last follow up was at two months.

Discussion
SJS and TEN are life threatening immune complex
hypersensitivity reactions. They are progressive, severe
variants of Erythema multiforme spectrum with drugs being
the most common associations.
SJS can be differentiated from other skin conditions
on 3 clinical criteria: the pattern of individual skin lesions,
distribution of lesions and the extent of epidermal
detachment.7 The characteristic findings in SJS are
widespread erythematous or purpuric macules which form
flat atypical target lesions as the disease progresses to cause
full thickness epithelial necrosis.2 Our patient had
developed erythematous macules but did not progress to
form vesicular and target lesions. This suggests either a
prevention of the development of full thickness epithelial
necrosis due to early effective treatment or an atypical
presentation. The lesions were widespread as compared to
Erythema Multiforme which is localized. No epidermal
detachment was seen which is more suggestive of TEN due
to greater severity. The degree of confluence of lesions was
higher in our patient than found in SJS alone but lesser as
compared to TEN. It was diagnosed as drug induced based
upon the fact that a temporal relationship with
acetaminophen was established and the patient could
correlate the increased exposure with increased severity of
symptoms. The fever which preceded the appearance of the
rash was most probably due to viral infection since her son
was suffering from fever and flu like symptoms.
The first step in the management of patients with
drug induced SJS is immediate withdrawal of the offending
agent followed by supportive care, as done in our patient.
Garcia-Doval et al.8 report that earlier the drug is withdrawn
the better the prognosis while exposure to drugs with longer
half-lives increases the risk of death. Supportive care must
include management of fluid and electrolyte requirements.8
Our patient was administered corticosteroids as they reduce
the inflammatory process which is the major cause of skin
necrolysis. Management of SJS patients with steroids
however, remains debatable as steroid use may also increase
wound healing time, the risk of infection and cause
gastrointestinal bleeding. Patterson et al highlighted its
effectiveness in treating SJS in which none of the patients
suffered any side effects.9 However, no well controlled trials
have been conducted to support the claim. Another
efficacious option available in treating SJS and TEN is the
use of intravenous Immunoglobulins.Several retrospective
studies have shown it to be effective in SJS management
when used in combination with corticosteroids.10 However,
being expensive its use is limited, particularly in developing
countries like Pakistan.
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hypersensitivity: results of a single-blinded trial. Clin Exp Allergy 2002; 32:
1366-9.

Conclusion
As per our experience, the causative agent is highly
suggestive to be acetaminophen since no other drug was
used and a temporal relationship between acetaminophen
use and severity in symptoms was proven. However, other
causes particularly viral infection could not be ruled out
since oral provocation test to confirm acetaminophen
involvement was avoided due to associated risks. It is hence
important for the clinicians to be alert to severe
hypersensitivity reactions even with drugs which are
considered to be potentially safe such as acetaminophen.
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